Th17 cells have been described as short lived, but this view is at odds with their capacity to
trigger protracted damage to normal and transformed tissues. We report that Th17 cells, …

Effector cells derived from central memory CD8 + T cells were reported to engraft and
survive better than those derived from effector memory populations, suggesting that they are …

Solid tumors are complex masses with a local microenvironment, or stroma, that supports
tumor growth and progression. Among the diverse tumor-supporting stromal cells is a …

T-cell–based immunotherapies can be effective in the treatment of large vascularized tumors,
but they rely on adoptive transfer of substantial numbers (∼20 million) of tumor-specific T …

The transcriptional repressor Blimp-1 promotes the differentiation of CD8 + T cells into short-lived
effector cells (SLECs) that express the lectin-like receptor KLRG-1, but how it operates …

Purpose: Immune checkpoint inhibitors have recently revolutionized cancer immunotherapy.
On the basis of data showing KIR-ligand mismatched natural killer (NK) cells reduce the risk …

For more than a decade, investigators have pursued methods to genetically engineer natural
killer (NK) cells for use in clinical therapy against cancer. Despite considerable advances …

Background Coronavirus disease 2019 (COVID-19) requiring hospitalization is characterized
by robust antibody production, dysregulated immune response, and immunothrombosis. …

Purpose: Trials of adoptive natural killer (NK)-cell immunotherapy for hematologic malignancies
have thus far shown only marginal effects, despite the potent in vitro antitumor activity of …

Adoptive transfer of natural killer (NK) cells can induce remission in patients with relapsed/refractory
leukemia and myeloma. However, to date, clinical efficacy of NK cell …